UPDATE
: Monday, September 7, 2020
Home
Login
Mobile Version
All
Hospital
Pharma
Bio
Korea‘s Bio Industry
Device/ICT
Policy
People
Life science
Special
Innovation for Survival
Korea’s medical culture series
Korea’s New Candidate Drug Watch List
Special Series in Celebration of KBR's 1st Anniversary
Interview with foreign envoys
Special Series in Celebration of KBR’s 2nd Anniversary
Interview with global pharma
Special Series in Celebration of KBR’s 3rd Anniversary
Special Series in Celebration of KBR’s 4th Anniversary
ASCO 2020 Highlights
Opinion
Reporter’s Notebook
Search
트위터
페이스북
RSS
상단여백
제목보기
제목보기
제목+내용
Daewoong teams up with ADM Korea to develop new drugs
by Shim Hyun-tai
2020-02-12 15:58
Bridge Biotherapeutics, Konkuk University to develop back-eye diseases treatment
by Lee Han-soo
2020-02-12 14:49
GC’s sales rose but profits fell in 2019
by Lee Han-soo
2020-02-12 11:40
Medipost’s sales edge up, losses widen last year
by Lee Han-soo
2020-02-12 11:40
MSD Korea workers unhappy with spinoff plan
by Kim Yun-mi
2020-02-11 14:57
라인
Fake news about new coronavirus drug candidate goes viral
by Kim Yun-mi
2020-02-11 12:33
Novartis' new drug for mutated lung cancer gets insurance coverage
by Kim Yun-mi
2020-02-10 18:29
Hanmi Pharmaceutical renews yearly profit records
by Shim Hyun-tai
2020-02-10 12:29
Court acquits Nature Cell president of stock manipulation
by Jeong Sae-im
2020-02-07 18:40
Handok’s medicine for childhood hypophosphatasia gets insurance benefits
by Kim Eun-young
2020-02-07 15:59
라인
AstraZeneca Korea leaves umbrella trade union
by Jeong Sae-im
2020-02-07 14:35
Experts caution against hasty use of Olumiant for new coronavirus
by Kim Yun-mi
2020-02-06 16:08
MSD to spin off women’s health, biosimilars under new firm
by Kim Yun-mi
2020-02-06 13:07
Helixmith presents study results of neuropathic pain treatment
by Shim Hyun-tai
2020-02-05 18:43
‘Baricitinib emerges as potential treatment for new coronavirus’
by Lee Han-soo
2020-02-05 16:32
라인
Medytox, Daewoong in final battle over BTX strain ownership
by Jeong Sae-im
2020-02-05 12:41
Interferon, Kaletra to get insurance benefit for new coronavirus treatment
by Kim Yun-mi
2020-02-04 16:39
‘Gilead’s drug candidate effective to fight new coronavirus’
by Kim Yun-mi
2020-02-04 16:39
Boryung Holdings sets up US offshoot
by Lee Han-soo
2020-02-03 16:28
Drug firms minimize gatherings, hospital visits as coronavirus fear spreads
by Jeong Sae-im
2020-02-03 15:21
-
이전
11
12
13
14
15
16
17
18
19
20
다음
-
176 civic groups furious over government-doctors deal
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
UBcare wins patent for tech to monitor suspected infectious diseases
SCM Lifescience punished for delaying adverse reaction report
176 civic groups furious over government-doctors deal
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
UBcare wins patent for tech to monitor suspected infectious diseases
SCM Lifescience punished for delaying adverse reaction report
여백
Most viewed
1
‘Cyramza helped improve gastric cancer treatment in Korea’
2
‘Reduced-dose prasugrel effective for ACS patients undergoing PCI’
3
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
4
SNUBH develops AI model predicting patients at risk of cerebral aneurysm
5
Novavax releases encouraging phase-1 results on Covid-19 vaccine candidate
6
LG Chem, SK Bioscience end sales partnership with Daewoong
7
UBcare wins patent for tech to monitor suspected infectious diseases
8
176 civic groups furious over government-doctors deal
9
Recovered Covid-19 patients suffer from aftereffects – for long
10
Regulator OKs JW Pharma's rheumarthritis drug for treating giant cell arteries
여백
Opinion
[Column] Correct diagnosis leads to proper treatment
[Column] How ongoing doctors’ strike is different from 20 years ago
A Korean-American Doctor asks: Is Korea truly in 2020?
여백
Back to Top